Home/Filings/4/0001214659-17-007049
4//SEC Filing

Goldfarb Robert I 4

Accession 0001214659-17-007049

CIK 0001625288other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 10:37 AM ET

Size

11.7 KB

Accession

0001214659-17-007049

Insider Transaction Report

Form 4
Period: 2017-11-29
Goldfarb Robert I
Chief Operating Officer
Transactions
  • Other

    Class A Warrants (right to buy)

    2017-11-29+2,4002,400 total
    Exercise: $0.25From: 2017-11-29Exp: 2018-01-31Common Stock (2,400 underlying)
  • Other

    Class C Warrants (right to buy)

    2017-11-29+2,4002,400 total
    Exercise: $0.50From: 2017-11-29Exp: 2018-07-14Common Stock (2,400 underlying)
  • Other

    Common Stock

    2017-11-29+644,2271,024,000 total
  • Other

    Class B Warrants (right to buy)

    2017-11-29+2,4002,400 total
    Exercise: $0.38From: 2017-11-29Exp: 2018-05-07Common Stock (2,400 underlying)
Footnotes (5)
  • [F1]As adjusted to reflect a one-for-six reverse split of the issuer's common stock effective November 29, 2017
  • [F2]Acquired in exchange for all of Robert Goldfarb's shares of Intiva BioPharma Inc.
  • [F3]Acquired in exchange for all of Robert Goldfarb's Class A warrants of Intiva BioPharma Inc.
  • [F4]Acquired in exchange for all of Robert Goldfarb's Class B warrants of Intiva BioPharma Inc.
  • [F5]Acquired in exchange for all of Robert Goldfarb's Class C warrants of Intiva BioPharma Inc.

Issuer

Intiva BioPharma Inc.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001337910

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 10:37 AM ET
Size
11.7 KB